Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 27
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Protective Effect of Placental Mesenchymal Stromal Cells in an In Vitro Model of Parkinson's Disease Using Differentiated Neuroblastoma Cells

  • Almudena Coto-Vilcapoma
  • Laura Sánchez-Carretero
  • Daniel Arenas-Gonzalez
  • José A Molina
  • María José Morán-Jiménez
  • Paz de la Torre
  • Ana I Flores
  • Merino Martín, José Joaquín
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder. It is characterized by the accumulation of misfolded α-synuclein (α-syn) and progressive loss of dopaminergic neurons in the substantia nigra. Due to the limitations of current therapies, mesenchymal stromal cell (MSC) transplantation has emerged as a promising neuroprotective strategy. This study evaluated the neuroprotective potential of decidua-derived mesenchymal stromal cells (DMSCs) in vitro using a human neuroblastoma cell line (NB69) exposed to the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) as a PD model. The NB69 cells were differentiated into a mature dopaminergic phenotype using dibutyryl cyclic adenosine monophosphate (dbcAMP) and then exposed to MPP+. In proliferative NB69 cells, the effect of DMSCs was masked by their inherent antitumor activity against the neuroblastoma phenotype. Conversely, in the differentiated NB69 model, DMSCs demonstrated a significant protective role against MPP+-induced cytotoxicity. Interestingly, the mechanism by which DMSCs might exert a neuroprotective effect against MPP+ damage in differentiated NB69 cells appears to involve improving mitochondrial function by reducing free radicals. In summary, these findings suggest that DMSCs exert a neuroprotective effect in a dopaminergic-like context and highlight the importance of using differentiated cell models to accurately evaluate cell-based therapies for PD in the striatum.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Video conference vs face-to-face group psychotherapy for distressed cancer survivors, A randomized controlled trial

  • Lleras, María|||0000-0002-7767-1625
  • Medina, Joan Carles|||0000-0002-4550-2157
  • Vives Brosa, Jaume|||0000-0001-5412-7275
  • Casellas-Grau, Anna|||0000-0003-2919-0509
  • Marzo, Jose Luis
  • Borras, Josep M|||0000-0001-7330-6308
  • Ochoa, Cristian|||0000-0002-4508-0951
Objective: This study assesses the effectiveness of face-to-face group positive psychotherapy for cancer survivors (PPC) compared to its online adaptation, online group positive psychotherapy for cancer survivors (OPPC), which is held via videoconference. A two-arm, pragmatic randomized controlled trial was conducted to examine the effects of both interventions on emotional distress, post-traumatic stress symptoms (PTSS), and post-traumatic growth (PTG) among cancer survivors and analyze attrition to treatment. Methods: Adult women with a range of cancer diagnoses were invited to participate if they experienced emotional distress at the end of their primary oncological treatment. Emotional distress, PTSS, and PTG were assessed at baseline, immediately after treatment, and 3 months after treatment. Intention-to-treat analyses were carried out using general linear mixed models to test the effect of the interventions overtime. Logistic regressions were performed to test differential adherence to treatment and retention to follow-up. Results: A total of 269 individuals participated. The observed treatment effect was significant in both modalities, PPC and OPPC. Emotional distress (b = -2.24, 95% confidence interval [CI] = -3.15 to -1.33) and PTSS (b = -3.25, 95% CI = -4.97 to -1.53) decreased significantly over time, and PTG (b = 3.08, 95% CI = 0.38-5.78) increased significantly. Treatment gains were sustained across outcomes and over time. Analyses revealed no significant differences between modalities of treatment, after adjusting for baseline differences, finding that OPPC is as effective and engaging as PPC. Conclusions: The OPPC treatment was found to be effective and engaging for female cancer early survivors. These results open the door for psycho-oncology interventions via videoconference, which are likely to lead to greater accessibility and availability of psychotherapy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Stress management or Post-traumatic growth facilitation to diminish distress in cancer survivors? A randomized controlled trial

  • Ochoa, Cristian|||0000-0002-4508-0951
  • Casellas-Grau, Anna|||0000-0003-2919-0509
  • Lleras, María|||0000-0002-7767-1625
  • Medina, Joan Carles|||0000-0002-4550-2157
  • Vives Brosa, Jaume|||0000-0001-5412-7275
This randomized controlled trial compared the efficacy of cognitive behavioral stress management (CBSM) and positive psychotherapy in cancer (PPC) to reduce post-traumatic stress symptoms (PTSS) and distress, and to promote post-traumatic growth (PTG) in cancer survivors. Participants were 140 adult women randomly allocated to CBSM (n = 73) or PPC (n = 67). PTSS, distress, and PTG were assessed at pre- and post-intervention, and at 3- and 12-month follow-ups. Analysis showed PPC was more effective in decreasing PTSS (b = -7.61, p <.001) and distress (b = -3.66; p <.001) than CBSM, but neither therapy significantly increased PTG (b = 0.77, p =.76). The relational veracity of PTG and its role predicting reduced PTSS was observed only in the PPC arm. In conclusion, PPC appears to be a valid therapeutic option for assimilating and accommodating the experience of cancer after treatment completion.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Temporal trends and social inequities in adolescent and young adult mental health disorders in Catalonia, Spain, a 2008-2022 primary care cohort study

  • Lozano-Sánchez, Ana
  • Aragonès, Enric|||0000-0002-5245-4667
  • López Jiménez, Tomàs|||0000-0001-8255-4936
  • Bennett, Matthew|||0000-0002-8309-8191
  • Evangelidou, Stella|||0000-0002-7107-3229
  • Francisco, Esther|||0000-0001-8086-0817
  • García, Myriam|||0000-0002-4896-9772
  • Malgosa Gasol, Estel|||0000-0003-0727-5392
  • Codern-Bové, Núria|||0000-0003-0210-7488
  • Guzmán-Molina, Claudia|||0000-0002-8083-4368
  • Jacques-Aviñó, Constanza|||0000-0001-8506-780X
The prevalence of mental health disorders in children, teens, and young adults is rising at an alarming rate. This study aims to explore time trends in the incidence of mental disorders among young people in Catalonia, Spain from 2008 to 2022, focusing on the effects of the COVID-19 pandemic and from the perspective of social inequities. A cohort study using primary care records from the SIDIAP database was conducted. It included 2,088,641 individuals aged 10 to 24 years. We examined the incidence of depressive, anxiety, eating, and attention deficit/hyperactivity disorders, stratified by sex, age, deprivation, and nationality. All disorders reflected an increasing trend throughout the study period: depressive disorders (IRR: 2.44, 95% CI: 2.31-2.59), anxiety disorders (IRR: 2.33, 95% CI: 2.27-2.39), ADHD (IRR: 2.33, 95%CI: 2.17-2.50), and eating disorders (IRR: 3.29, 95% CI: 3.01-3.59). A significant increase in incidence was observed after the outbreak of the COVID-19 pandemic. In 2022, anxiety disorders were most frequent, with an incidence rate (IR) of 2,537 per 100,000 persons-year (95% CI: 2,503-2,571). Depressive disorders followed with an IR of 471 (95% CI: 458-486), ADHD with an IR of 306 (95% CI: 295-317) and eating disorders with an IR of 249 (95% CI: 239-259). Significant associations were reported with sex, age, deprivation, and nationality. The incidence of all studied disorders has steadily increased, reaching unprecedented levels during the pandemic. Understanding these trends is essential for an appropriate healthcare response, while addressing the non-medical determinants, requires action across all sectors of society. The online version contains supplementary material available at 10.1186/s13034-024-00849-2.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Therapeutic alliance in a stepped digital psychosocial intervention for breast cancer patients, findings from a multicentre randomised controlled trial

  • Flix-Valle, Aida|||0000-0002-1962-330X
  • Medina, Joan Carles|||0000-0002-4550-2157
  • Souto-Sampera, Arnau|||0000-0001-5299-3065
  • Arizu-Onassis, Alejandra|||0000-0001-8497-0263
  • Juan Linares, Eva|||0000-0003-3167-9717
  • Serra Blasco, Maria|||0000-0001-5793-9906
  • Ciria Suarez, Laura|||0000-0002-1388-6686
  • Feixas i Viaplana, Guillem|||0000-0002-6288-6009
  • Ochoa, Cristian|||0000-0002-4508-0951
Background Action mechanisms of therapeutic alliance in stepped and digital interventions remain unclear. Aims (a) To compare the development of therapeutic alliance between psychosocial treatment as usual (PTAU) and a stepped digital intervention designed to prevent distress in cancer patients; (b) to analyse the level of agreement between patients' and therapists' therapeutic alliance ratings; and (c) to explore variables associated with therapeutic alliance in the digital intervention. Method A multicentre randomised controlled trial with 184 newly diagnosed breast cancer women was conducted. Patients were assigned to digital intervention or PTAU. Therapeutic alliance was assessed at 3, 6 and 12 months after inclusion using the working alliance inventory for patients and therapists. Age, usability (system usability scale), satisfaction (visual analogue scale), type and amount of patient-therapist communication were analysed as associated variables. Results Patients and therapists established high therapeutic alliance in the digital intervention, although significantly lower compared with PTAU. The development of patients' therapeutic alliance did not differ between interventions, unlike that of the therapists. No agreement was found between patients' and therapists' therapeutic alliance ratings. Patients' therapeutic alliance was associated with usability and satisfaction with app, whereas therapists' therapeutic alliance was associated with satisfaction with monitoring platform. Conclusions A stepped digital intervention for cancer patients could develop and maintain strong therapeutic alliance. Neither the type nor amount of communication affected patients' therapeutic alliance, suggesting that flexible and available digital communication fosters a sense of care and connection. The association between usability and satisfaction with digital tools highlights their importance as key therapeutic alliance components in digital settings.
Repisalud
Publicación Artículo científico (JournalArticle)

Tumor-derived pericytes driven by EGFR mutations govern the vascular and immune microenvironment of gliomas

  • Segura-Collar, Berta
  • Garranzo-Asensio, Maria
  • Herranz, Beatriz
  • Hernandez-SanMiguel, Esther
  • Cejalvo, Teresa
  • Casas, Bárbara S
  • Matheu, Ander
  • Pérez-Núñez, Ángel
  • Sepúlveda-Sánchez, Juan Manuel
  • Hernández-Laín, Aurelio
  • Palma, Verónica
  • Gargini, Ricardo
  • Sánchez-Gómez, Pilar
The extraordinary plasticity of glioma cells allows them to contribute to different cellular compartments in tumor vessels, reinforcing the vascular architecture. It was recently revealed that targeting glioma-derived pericytes, which represent a big percentage of the mural cell population in aggressive tumors, increases the permeability of the vessels and improves the efficiency of chemotherapy. However, the molecular determinants of this transdifferentiation process have not been elucidated. Here we show that mutations in epidermal growth factor receptor (EGFR) stimulate the capacity of glioma cells to function as pericytes in a BMX (bone marrow and X-linked) and SOX9-dependent manner. Subsequent activation of platelet-derived growth factor receptor beta (PDGFRβ) in the vessel walls of EGFR mutant gliomas stabilized the vasculature and facilitated the recruitment of immune cells. These changes in the tumor microenvironment conferred a growth advantage to the tumors but also rendered them sensitive to pericyte-targeting molecules such as ibrutinib or sunitinib. In the absence of EGFR mutations, high-grade gliomas were enriched in blood vessels but showed a highly disrupted blood-brain-barrier due to the decreased BMX/SOX9 activation and pericyte coverage, which led to poor oxygenation, necrosis, and hypoxia. Overall, these findingds identify EGFR mutations as key regulators of the glioma-to-pericyte transdifferentiation, highlighting the intricate relationship between the tumor cells and their vascular and immune milieu. Our results lay the foundations for a vascular-dependent stratification of gliomas and suggest different therapeutic vulnerabilities determined by the genetic status of EGFR.
Repisalud
Publicación Artículo científico (JournalArticle)

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

  • Pascual-García, Mónica
  • Bonfill-Teixidor, Ester
  • Planas-Rigol, Ester
  • Rubio-Perez, Carlota
  • Iurlaro, Raffaella
  • Arias, Alexandra
  • Cuartas, Isabel
  • Sala-Hojman, Ada
  • Escudero, Laura
  • Martínez-Ricarte, Francisco
  • Huber-Ruano, Isabel
  • Nuciforo, Paolo
  • Pedrosa, Leire
  • Marques, Carolina
  • Braña, Irene
  • Garralda, Elena
  • Vieito, María
  • Squatrito, Massimo
  • Pineda, Estela
  • Graus, Francesc
  • Espejo, Carmen
  • Sahuquillo, Juan
  • Tabernero, Josep
  • Seoane, Joan
Cancer response to immunotherapy depends on the infiltration of CD8+ T cells and the presence of tumor-associated macrophages within tumors. Still, little is known about the determinants of these factors. We show that LIF assumes a crucial role in the regulation of CD8+ T cell tumor infiltration, while promoting the presence of protumoral tumor-associated macrophages. We observe that the blockade of LIF in tumors expressing high levels of LIF decreases CD206, CD163 and CCL2 and induces CXCL9 expression in tumor-associated macrophages. The blockade of LIF releases the epigenetic silencing of CXCL9 triggering CD8+ T cell tumor infiltration. The combination of LIF neutralizing antibodies with the inhibition of the PD1 immune checkpoint promotes tumor regression, immunological memory and an increase in overall survival.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Impact of high dietary plant protein with or without marine ingredients in gut mucosa proteome of gilthead seabream (Sparus aurata, L.)

  • Estruch, Guillem
  • Monge-Ortiz, Raquel
  • Brown, Paul B.
  • Martínez-Llorens, Silvia|||0000-0002-9824-3267
  • Tomas-Vidal, A.|||0000-0002-2985-9324
  • Jover Cerda, Miguel|||0000-0001-9049-0573
  • Peñaranda, D.S.|||0000-0002-0861-976X
[EN] The digestive tract, particularly the intestine, represents one of the main sites of interactions with the environment, playing the gut mucosa a crucial role in the digestion and absorption of nutrients, and in the immune defence. Previous researches have proven that the fishmeal replacement by plant sources could have an impact on the intestinal status at both digestive and immune level, compromising relevant productive parameters, such as feed efficiency, growth or survival. In order to evaluate the long-term impact of total fishmeal replacement on intestinal mucosa, the gut mucosa proteome was analysed in fish fed with a fishmeal-based diet, against plant protein-based diets with or without alternative marine sources inclusion. Total fishmeal replacement without marine ingredients inclusion, reported a negative impact in growth and biometric parameters, further an altered gut mucosa proteome. However, the inclusion of a low percentage of marine ingredients in plant protein-based diets was able to maintain the growth, biometrics parameters and gut mucosa proteome with similar values to FM group. A total fishmeal replacement induced a big set of underrepresented proteins in relation to several biological processes such as intracellular transport, assembly of cellular macrocomplex, protein localization and protein catabolism, as well as several molecular functions, mainly related with binding to different molecules and the maintenance of the cytoskeleton structure. The set of downregulated proteins also included molecules which have a crucial role in the maintenance of the normal function of the enterocytes, and therefore, of the epithelium, including permeability, immune and inflammatory response regulation and nutritional absorption. Possibly, the amino acid imbalance presented in VM diet, in a long-term feeding, may be the main reason of these alterations, which can be prevented by the inclusion of 15% of alternative marine sources. Significance: Long-term feeding with plant protein based diets may be considered as a stress factor and lead to a negative impact on digestive and immune system mechanisms at the gut, that can become apparent in a reduced fish performance. The need for fishmeal replacement by alternative ingredients such as plant sources to ensure the sustainability of the aquaculture sector has led the research assessing the intestinal status of fish to be of increasing importance. This scientific work provides further knowledge about the proteins and biologic processes altered in the gut in response to plant protein based diets, suggesting the loss of part of gut mucosa functionality. Nevertheless, the inclusion of alternative marine ingredients was able to reverse these negative effects, showing as a feasible option to develop sustainable aquafeeds., The first author was supported by a contract-grant (Contrato Pre doctoral para la Formacion de Profesorado Universitario) from Subprogramas de Formacion y Movilidad within the Programa Estatal de Promocion del Talento y su Empleabilidad of the Ministerio de Educacion, Cultura y Deporte of Spain.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Intestinal Explant Cultures from Gilthead Seabream (Sparus aurata, L.) Allowed the Determination of Mucosal Sensitivity to Bacterial Pathogens and the Impact of a Plant Protein Diet

  • Peñaranda, D.S.|||0000-0002-0861-976X
  • Tomas-Vidal, A.|||0000-0002-2985-9324
  • Jover Cerda, Miguel|||0000-0001-9049-0573
  • Martínez-Llorens, Silvia|||0000-0002-9824-3267
  • Bäuerl, Christine
  • Estruch, Guillem
  • Pérez Martínez, Gaspar
[EN] The interaction between diet and intestinal health has been widely discussed, although in vivo approaches have reported limitations. The intestine explant culture system developed provides an advantage since it reduces the number of experimental fish and increases the time of incubation compared to similar methods, becoming a valuable tool in the study of the interactions between pathogenic bacteria, rearing conditions, or dietary components and fish gut immune response. The objective of this study was to determine the influence of the total substitution of fish meal by plants on the immune intestinal status of seabream using an ex vivo bacterial challenge. For this aim, two growth stages of fish were assayed (12 g): phase I (90 days), up to 68 g, and phase II (305 days), up to 250 g. Additionally, in phase II, the effects of long term and short term exposure (15 days) to a plant protein (PP) diet were determined. PP diet altered the mucosal immune homeostasis, the younger fish being more sensitive, and the intestine from fish fed short-term plant diets showed a higher immune response than with long-term feeding. Vibrio alginolyticus (V. alginolyticus) triggered the highest immune and inflammatory response, while COX-2 expression was significantly induced by Photobacterium damselae subsp. Piscicida (P. damselae subsp. Piscicida), showing a positive high correlation between the pro-inflammatory genes encoding interleukin 1 beta (IL1-beta), interleukin 6 (IL-6) and cyclooxygenase 2(COX-2)., The research was supported by a grant financed by the Spanish Ministerio de Economia y Competitividad AGL2015-70487-P. and Generalitat Valenciana, IDIFEDER/2020/029 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It was additionally granted by Contrato Pre-doctoral para la Formacion de Profesorado Universitario from Subprogramas de Formacion y Movilidad within the Programa Estatal de Promocion del Talento y su Empleabilidad of the Ministerio de Educacion, Cultura y Deporte of Spain.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Long -term feeding with high plant protein based diets in gilthead seabream (Sparus aurata, L.) leads to changes in the inflammatory and immune related gene expression at intestinal level

  • Estruch-Cucarella, Guillem
  • Collado, Mª Carmen
  • Monge-Ortiz, Raquel
  • Perez Martinez, Gaspar
  • Tomas-Vidal, A.|||0000-0002-2985-9324
  • Jover Cerda, Miguel|||0000-0001-9049-0573
  • Peñaranda, D.S.|||0000-0002-0861-976X
  • Martínez-Llorens, Silvia|||0000-0002-9824-3267
[EN] Background: In order to ensure sustainability of aquaculture production of carnivourous fish species such as the gilthead seabream (Sparus aurata, L.), the impact of the inclusion of alternative protein sources to fishmeal, including plants, has been assessed. With the aim of evaluating long-term effects of vegetable diets on growth and intestinal status of the on-growing gilthead seabream (initial weight = 129 g), three experimental diets were tested: a strict plant protein-based diet (VM), a fishmeal based diet (FM) and a plant protein-based diet with 15% of marine ingredients (squid and krill meal) alternative to fishmeal (VM+). Intestines were sampled after 154 days. Besides studying growth parameters and survival, the gene expression related to inflammatory response, immune system, epithelia integrity and digestive process was analysed in the foregut and hindgut sections, as well as different histological parameters in the foregut. Results: There were no differences in growth performance (p = 0.2703) and feed utilization (p = 0.1536), although a greater fish mortality was recorded in the VM group (p = 0.0141). In addition, this group reported a lower expression in genes related to pro-inflammatory response, as Interleukine-1 beta (il1 beta, p = 0.0415), Interleukine-6 (il6, p = 0.0347) and cyclooxigenase-2 (cox2, p = 0.0014), immune-related genes as immunoglobulin M (igm, p = 0.0002) or bacterial defence genes as alkaline phosphatase (alp, p = 0.0069). In contrast, the VM+ group yielded similar survival rate to FM (p = 0.0141) and the gene expression patterns indicated a greater induction of the inflammatory and immune markers (il1 beta, cox2 and igm). However, major histological changes in gut were not detected. Conclusions: Using plants as the unique source of protein on a long term basis, replacing fishmeal in aqua feeds for gilthead seabream, may have been the reason of a decrease in the level of different pro-inflammatory mediators (il1 beta, il6 and cox2) and immune-related molecules (igm and alp), which reflects a possible lack of local immune response at the intestinal mucosa, explaining the higher mortality observed. Krill and squid meal inclusion in vegetable diets, even at low concentrations, provided an improvement in nutrition and survival parameters compared to strictly plant protein based diets as VM, maybe explained by the maintenance of an effective immune response throughout the assay., The research has been partially funded by Vicerrectorat d'Investigacio, Innovacio i Transferencia of the Universitat Politecnica de Valencia, which belongs to the project Aquaculture feed without fishmeal (SP20120603). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Reglamentos de régimen interno de las Cooperativas de trabajo asociado y determinación de las condiciones de trabajo, Regulations governing the internal rules of worker cooperatives and determining working conditions

  • Escribano Gutiérrez, Juan
Los Reglamentos de régimen interno poseen, pese a su escaso tratamiento normativo y doctrinal, unas enormes potencialidades reguladoras de las condiciones de trabajo en las Cooperativas de Trabajo Asociado. Un examen exhaustivo de los estudios doctrinales aparecidos hasta la fecha nos permite comprobar que se carece de un tratamiento pormenorizado más allá de algún estudio clásico desde la perspectiva mercantilista. Por el contrario, no existen precedentes de este tipo de estudios respecto al análisis de su papel en la regulación de las condiciones de trabajo de las personas socias-trabajadoras. La exclusión constitutiva, a partir de la década de los 90, de tales personas socias del ámbito de aplicación del Derecho del Trabajo impide la aplicación de los instrumentos de regulación colectiva de las condiciones de trabajo por cuenta ajena, por lo que los Reglamentos son el único vehículo de regulación colectiva de sus condiciones de trabajo. Un análisis de las distintas normas cooperativas pone de manifiesto, además, la dispersión y heterogeneidad de los preceptos que regulan estos instrumentos de autorregulación. Por su parte, el carácter de los RRI difiere de los instrumentos tradicionales de regulación colectiva previstos por el Derecho del Trabajo. Por ello, se hace necesario un análisis de su naturaleza jurídica y límites. Por último, se analizarán algunos RRI de grandes cooperativas para comprobar si, efectivamente, están asumiendo la regulación de tales condiciones y en qué sentido lo afrontan. En concreto, se analizarán los RRI de las cooperativas Servicarne y Eroski. En el primer caso, por la polémica jurisprudencial que la rodea y poder comprobar si esta se traslada a su RRI. En el segundo caso, para comprobar como los RRI sirven, en ocasiones, para excluir la aplicación de importantes instituciones del Derecho del Trabajo en el interior de la Cooperativa de trabajo asociado., Despite their scant regulatory and doctrinal treatment, the Internal Regulations have enormous potential for regulating working conditions in worker co-operatives. An exhaustive examination of the doctrinal studies that have appeared to date shows that they lack detailed treatment beyond the odd classic study from a commercial perspective. On the contrary, there are no precedents for this type of study about the analysis of their role in the regulation of the working conditions of worker-members. The constitutive exclusion, from the 1990s onwards, of these members from the scope of application of labour law prevents the application of the instruments of collective regulation of the working conditions of employees, so that these regulations are the only vehicle for the collective regulation of their working conditions. An analysis of the various cooperative rules reveals, moreover, the dispersion and heterogeneity of the provisions governing these self-regulation instruments. For their part, the nature of these internal rules differs from the traditional instruments of collective regulation provided for by labour law. An analysis of their legal nature and limits is therefore necessary. Finally, some internal regulations of large cooperatives will be analysed to check whether and in what sense they are effectively taking on the regulation of such conditions. Specifically, the RRIs of the co-operatives Servicarne and Eroski will be analysed. In the first case, because of the jurisprudential controversy surrounding it and to be able to check whether this is reflected in their Internal Regulations. In the second case, to see how these Internal Regulations sometimes serve to exclude the application of important labour law institutions within the worker cooperative.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Associations between chronic exposure to bisphenols and parabens and gut microbiota in children

  • Rodrigo, Lourdes
  • Bressa, Carlo
  • Larrosa, Mar
  • Ramírez, Viviana
  • Gil-Izquierdo, Ángel
  • Sánchez-Muñoz, Cristóbal
  • Martínez-Burgos, María Alba
  • Zafra-Gómez, Alberto
  • Rivas, Ana
Bisphenols and parabens are endocrine-disrupting chemicals widely used in food packaging and personal care products. Early-life exposure to these compounds has been associated with adverse health effects, but their potential role in modulating the gut microbiota during childhood remains poorly understood. The objective of this study was to investigate the association between chronic exposure to bisphenols and parabens and gut microbiota diversity, composition, and function in children. A cross-sectional study in 97 Spanish children aged 4-12 year was conducted. Bisphenols and parabens in hair were quantified using ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS). Gut microbiota composition was assessed via 16S rRNA gene sequencing, and functional potential was inferred using PICRUSt2. Associations were explored using linear regression and random forest models, adjusting for age and sex. Total bisphenols and parabens were detected in 100 % of the children, with median concentrations of 311.33 ng/g and 1904.11 ng/g, respectively. No significant differences in overall gut microbiota diversity were observed between children with low and high exposure levels to bisphenols and parabens. However, regression models revealed associations between specific microbial genera and individual compounds. Additionally, bisphenol S was negatively associated with a predicted microbial pathway involved in methionine metabolism. Notably, Lachnospiraceae_UCG-001 emerged as a predictive genus for propylparaben exposure. Although gut microbiota composition was similar across exposure levels, specific taxa and functional pathways were linked to chronic bisphenol and paraben exposure. These findings support the need for further research on the health implications of early-life exposure to these endocrine-disrupting chemicals., This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project “PI20/01278” and “PI23/01359” and co-funded by the European Union; and co-funded project FEDER-Consejería de Salud y Familias, Junta de Andalucía “PE-0250–2019”, Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment

  • Rubio Pérez, Carlota
  • Planas Rigol, Ester
  • Trincado, Juan L.
  • Bonfill Teixidor, Ester
  • Arias Piñeiro, Alexandra
  • Marchese, Domenica
  • Iurlaro, Raffaella
  • Martínez Ricarte, Francisco Ramón
  • Escudero Monreal, Laura
  • Cordero Asanza, Esteban Xavier
  • Cicuendez López Ocaña, Marta
  • Nuciforo, Paolo Giovanni
  • Sahuquillo Barris, Joan
  • Tabernero Caturla, Josep
  • Seoane Suarez, Joan
  • Serna, Garazi
Microambient del càncer; Immunologia tumoral, Microambiente del cáncer; Inmunología tumoral, Cancer microenvironment; Tumour immunology, Brain metastases are the most common tumor of the brain with a dismal prognosis. A fraction of patients with brain metastasis benefit from treatment with immune checkpoint inhibitors (ICI) and the degree and phenotype of the immune cell infiltration has been used to predict response to ICI. However, the anatomical location of brain lesions limits access to tumor material to characterize the immune phenotype. Here, we characterize immune cells present in brain lesions and matched cerebrospinal fluid (CSF) using single-cell RNA sequencing combined with T cell receptor genotyping. Tumor immune infiltration and specifically CD8+ T cell infiltration can be discerned through the analysis of the CSF. Consistently, identical T cell receptor clonotypes are detected in brain lesions and CSF, confirming cell exchange between these compartments. The analysis of immune cells of the CSF can provide a non-invasive alternative to predict the response to ICI, as well as identify the T cell receptor clonotypes present in brain metastasis., The study was undertaken with the support of the Fundación Asociación Española contra el Cáncer (AECC), FERO (EDM), Ramón Areces Foundation, Cellex Foundation, BBVA (CAIMI), the ISCIII, FIS (PI16/01278), the Ministerio de Ciencia, Innovación y Universidades (SAF2017-89109-P; AEI/FEDER, UE), the Juan de la Cierva formación fellowship (C.R.-P. and L.E.), Sara Borrell fellowship (E.P-R.). We acknowledge support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Program/Generalitat de Catalunya. We also acknowledge the support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, and the Co-financing by the Spanish Ministry of Ministry of Science and Innovation with funds from the European Regional Development Fund (ERDF) corresponding to the 2014–2020 Smart Growth Operating Program.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition

  • Jiménez Bernal, Isabel
  • Carabia Juberó, Júlia
  • Bobillo Varela, Sabela
  • Palacio García, Carlos
  • Abrisqueta, Pau
  • Nieto Sáchica, Juan Camilo
  • Castellví Vives, Josep
  • Martínez Ricarte, Francisco Ramón
  • Boix, Joan
  • Purroy Zuriguel, Noelia
  • Puigdefabregas Horta, Lluis
  • Seoane Suarez, Joan
  • Crespo Maull, Marta
  • Pagès Geli, Carlota
  • Bosch, Francesc
XPO1; BTK; Sistema immunitari innat, XPO1; BTK; Sistema inmune innato, XPO1; BTK; Innate immune system, Background Patients diagnosed with primary central nervous system lymphoma (PCNSL) often face dismal outcomes due to the limited availability of therapeutic options. PCNSL cells frequently have deregulated B-cell receptor (BCR) signaling, but clinical responses to its inhibition using ibrutinib have been brief. In this regard, blocking nuclear export by using selinexor, which covalently binds to XPO1, can also inhibit BCR signaling. Selinexor crosses the blood–brain barrier and was recently shown to have clinical activity in a patient with refractory diffuse large B-cell lymphoma in the CNS. We studied selinexor alone or in combination with ibrutinib in pre-clinical mouse models of PCNSL. Methods Orthotopic xenograft models were established by injecting lymphoma cells into the brain parenchyma of athymic mice. Tumor growth was monitored by bioluminescence. Malignant cells and macrophages were studied by immunohistochemistry and flow cytometry. Results Selinexor blocked tumor growth and prolonged survival in a bioluminescent mouse model, while its combination with ibrutinib further increased survival. CNS lymphoma in mice was infiltrated by tumor-promoting M2-like macrophages expressing PD-1 and SIRPα. Interestingly, treatment with selinexor and ibrutinib favored an anti-tumoral immune response by shifting polarization toward inflammatory M1-like and diminishing PD-1 and SIRPα expression in the remaining tumor-promoting M2-like macrophages. Conclusions These data highlight the pathogenic role of the innate immune microenvironment in PCNSL and provide pre-clinical evidence for the development of selinexor and ibrutinib as a new promising therapeutic option with cytotoxic and immunomodulatory potential., This work was supported by research funding from the Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias (PI17/00950, M.C., PI17/00943, F.B, PI18/01392, P.A., PI16/01278, J.S) cofinanced by the European Regional Development Fund (ERDF); Fundación Asociación Española Contra el Cáncer (M.C. and P.A.) and Gilead Fellowships (GLD16/00144, GLD18/00047, F.B). M.C. holds a contract from Ministerio de Ciencia, Innovación y Universidades (RYC-2012-12018). S.B. is the recipient of a postdoctoral fellowship from Fundación Alfonso Martin Escudero.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma

  • Escudero Monreal, Laura
  • Llort Sales, Anna
  • Arias Piñeiro, Alexandra
  • Diaz-Navarro, Ander
  • Martínez Ricarte, Francisco Ramón
  • Rubio Pérez, Carlota
  • Mayor Ferreras, Regina Gabriela
  • Caratú, Ginevra
  • Martinez Saez, Elena Antima
  • Vázquez Méndez, Josefa Élida
  • Hladun Alvaro, Raquel
  • Gros Subias, Luís
  • Ramon y Cajal Agüeras, Santiago
  • Poca Pastor, Ma Antonia
  • Sahuquillo Barris, Joan
  • Gallego Melcón, Soledad
  • Seoane Suarez, Joan
Genètica del càncer; Càncer del SNC; Càncer pediàtric, Genética del cáncer; Cáncer del SNC; Cáncer pediátrico, Cancer genetics; CNS cancer; Paediatric cancer, The molecular characterisation of medulloblastoma, the most common paediatric brain tumour, is crucial for the correct management and treatment of this heterogenous disease. However, insufficient tissue sample, the presence of tumour heterogeneity, or disseminated disease can challenge its diagnosis and monitoring. Here, we report that the cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) recapitulates the genomic alterations of the tumour and facilitates subgrouping and risk stratification, providing valuable information about diagnosis and prognosis. CSF ctDNA also characterises the intra-tumour genomic heterogeneity identifying small subclones. ctDNA is abundant in the CSF but barely present in plasma and longitudinal analysis of CSF ctDNA allows the study of minimal residual disease, genomic evolution and the characterisation of tumours at recurrence. Ultimately, CSF ctDNA analysis could facilitate the clinical management of medulloblastoma patients and help the design of tailored therapeutic strategies, increasing treatment efficacy while reducing excessive treatment to prevent long-term secondary effects., We would like to thank the patients at the Vall d’Hebron Hospital that were enrolled in the study and their families. The study was undertaken with the support of the Fundación Asociación Española contra el Cáncer (AECC), FERO (EDM), Ramón Areces Foundation, Cellex Foundation, BBVA (CAIMI), the ISCIII, FIS (PI16/01278) and the Juan de la Cierva fellowship (L.E). X.S.P. is supported by Ministerio de Economía y Competitividad (MINECO) SAF2013-45836-R and CIBERONC; A.D.N. is supported by the Department of Education of the Basque Government (grant number PRE_2017_1_0100). We thank CERCA Programme/Generalitat de Catalunya for institutional support.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

  • Janin, Maxime
  • Ortiz‑Barahona, Vanessa
  • Castro de Moura, Manuel
  • Martínez‑Cardús, Anna
  • Llinàs‑Arias, Pere
  • Soler, Marta
  • Arias Piñeiro, Alexandra
  • Cuartas Maza, Ma Isabel
  • Seoane Suarez, Joan
Resultado clínico; Epitranscriptómica; Glioma, Clinical outcome; Epitranscriptomics; Glioma, Resultat clínic; Epitranscriptòmica; Glioma, Tumors have aberrant proteomes that often do not match their corresponding transcriptome profiles. One possible cause of this discrepancy is the existence of aberrant RNA modification landscapes in the so-called epitranscriptome. Here, we report that human glioma cells undergo DNA methylation-associated epigenetic silencing of NSUN5, a candidate RNA methyltransferase for 5-methylcytosine. In this setting, NSUN5 exhibits tumor-suppressor characteristics in vivo glioma models. We also found that NSUN5 loss generates an unmethylated status at the C3782 position of 28S rRNA that drives an overall depletion of protein synthesis, and leads to the emergence of an adaptive translational program for survival under conditions of cellular stress. Interestingly, NSUN5 epigenetic inactivation also renders these gliomas sensitive to bioactivatable substrates of the stress-related enzyme NQO1. Most importantly, NSUN5 epigenetic inactivation is a hallmark of glioma patients with long-term survival for this otherwise devastating disease., This work was supported by a European Research Council (ERC) Advanced Grant under the European Community’s Seventh Framework Program (FP7/2007-2013)/ERC Grant Agreement No. 268626—EPINORC project (to M. Esteller), the Ministerio de Economía y Competitividad (MINECO) under Grant No. SAF2014-55000-R (to M. Esteller) and the Instituto de Salud Carlos III (ISCIII), under the FIS PI16/01278 Project (to J. Seoane), the Integrated Project of Excellence no. PIE13/00022 (ONCOPROFILE) (to M. Esteller), CIBER 2016 CB16/12/00312 (CIBERONC) (to M. Esteller), co-financed by the European Development Regional Fund, ‘A way to achieve Europe’ ERDF, the AGAUR—Catalan Government (Project No. 2009SGR1315 and 2014SGR633) (to M. Esteller), the Cellex Foundation (to M. Esteller), Obra Social “La Caixa” (to M. Esteller), the CERCA Program and the Health and Science Departments of the Catalan Government (Generalitat de Catalunya) (to M. Esteller) and a grant from the National Health and Medical Research Council of Australia (APP1061551, to TP). M.W. Boudreau is a member of the NIH Chemistry-Biology Interface Training Program (T32-GM070421).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Positive psychotherapy for distressed cancer survivors, posttraumatic growth facilitation reduces posttraumatic stress

  • Ochoa, Cristian|||0000-0002-4508-0951
  • Casellas-Grau, Anna|||0000-0003-2919-0509
  • Vives Brosa, Jaume|||0000-0001-5412-7275
  • Font Guiteras, Antoni|||0000-0001-5957-9799
  • Borras, Josep M.|||0000-0001-7330-6308
There is increasing evidence that positive life changes, such as posttraumatic growth (PTG), can result from the experience of coping with cancer. However, no interventions have been specifically designed to facilitate the development of PTG in cancer. In this article, we describe and assess the results of Positive Psychotherapy for Cancer (PPC) survivors. It aims to facilitate PTG as a way of achieving significant reductions in the symptoms of emotional distress and posttraumatic stress. In addition, the corroboration of this PTG facilitation is assessed using interpersonal indicators. Method: We allocated 126 consecutive survivors of cancer with high levels of emotional distress and who were seeking psychological support to either an experimental group (PPC) or a waiting list group. Results: The PPC group obtained significantly better results after treatment than the control group, showing reduced distress, decreased posttraumatic symptoms, and increased PTG. The benefits were maintained at 3 and 12 months' follow-up. Participants' PTG was correlated to the PTG that their significant others attributed to them, corroborating PTG facilitation. Conclusions: PPC appears to promote significant long-term PTG and can reduce emotional distress and posttraumatic stress in cancer survivors. In addition, PTG facilitation induced by PPC is corroborated by significant others.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

  • Janin, Maxime|||0000-0003-1013-4128
  • Ortiz-Barahona, V.
  • de Moura, M. C.
  • Martínez Cardús, Anna|||0000-0002-3937-8794
  • Llinàs-Arias, Pere|||0000-0002-3666-0532
  • Soler, Marta|||0000-0002-6656-957X
  • Nachmani, D.
  • Pelletier, Joffrey|||0000-0001-9174-044X
  • Schumann, U.
  • Calleja-Cervantes, María Eréndira|||0000-0003-0688-0793
  • Moran, S.|||0000-0003-4192-8983
  • Guil, Sonia|||0000-0002-2257-3331
  • Bueno-Costa, Alberto|||0000-0001-8700-2540
  • Piñeyro, David|||0000-0001-5633-3339
  • Perez-Salvia, Montserrat
  • Rosselló-Tortella, M.
  • Piqué, Laia
  • Bech-Serra, Joan-Josep|||0000-0003-3486-781X
  • De La Torre Gómez, Gisela Carolina|||0000-0001-9363-291X
  • Vidal, August|||0000-0001-5727-2099
  • Martínez-Iniesta, M.
  • Martín-Tejera, J. F.
  • Villanueva, Alejandro|||0000-0001-5164-0006
  • Arias, Alexandra
  • Cuartas, Isabel
  • Aransay, Ana M.|||0000-0002-8271-612X
  • La Madrid, A. M.
  • Carcaboso, Angel M.|||0000-0002-8485-426X
  • Santa-Maria, V.
  • Mora, J.
  • Fernández, Agustín F.|||0000-0002-3792-4085
  • Fraga, M. F.
  • Aldecoa, Iban|||0000-0001-5774-7453
  • Pedrosa, Leire|||0000-0002-1852-4975
  • Graus Ribas, Francesc|||0000-0002-8924-8322
  • Vidal, Noemí|||0000-0002-2852-6667
  • Martinez, Fina|||0000-0002-0940-1025
  • Tortosa, Avelina|||0000-0002-9080-2976
  • Carrato, Cristina|||0000-0002-1953-8287
  • Balañá, Carmen|||0000-0003-0771-0390
  • Boudreau, M. W.
  • Hergenrother, P. J.
  • Kötter, P.
  • Entian, K. D.
  • Hench, Jürgen
  • Frank, Stephan|||0000-0001-6165-0187
  • Mansouri, S.
  • Zadeh, G.
  • Dans, P. D.
  • Orozco López, Modesto|||0000-0002-8608-3278
  • Thomas, Gareth J.
  • Blanco, Sandra
  • Seoane Suárez, Joan|||0000-0002-6541-5974
  • Preiss, T.
  • Pandolfi, P. P.
  • Esteller, M.|||0000-0003-4490-6093
Tumors have aberrant proteomes that often do not match their corresponding transcriptome profiles. One possible cause of this discrepancy is the existence of aberrant RNA modification landscapes in the so-called epitranscriptome. Here, we report that human glioma cells undergo DNA methylation-associated epigenetic silencing of NSUN5, a candidate RNA methyltransferase for 5-methylcytosine. In this setting, NSUN5 exhibits tumor-suppressor characteristics in vivo glioma models. We also found that NSUN5 loss generates an unmethylated status at the C3782 position of 28S rRNA that drives an overall depletion of protein synthesis, and leads to the emergence of an adaptive translational program for survival under conditions of cellular stress. Interestingly, NSUN5 epigenetic inactivation also renders these gliomas sensitive to bioactivatable substrates of the stress-related enzyme NQO1. Most importantly, NSUN5 epigenetic inactivation is a hallmark of glioma patients with long-term survival for this otherwise devastating disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

  • Pascual-García, Mónica|||0000-0002-9768-0641
  • Bonfill-Teixidor, Ester|||0000-0002-9260-448X
  • Planas-Rigol, Ester|||0000-0001-5948-2241
  • Rubio-Perez, Carlota|||0000-0002-1921-168X
  • Iurlaro, Raffaella|||0000-0003-1019-6679
  • Arias, Alexandra
  • Cuartas, Isabel
  • Sala-Hojman, Ada
  • Escudero, Laura|||0000-0001-7385-673X
  • Martinez-Ricarte, Fran|||0000-0003-4567-0828
  • Huber-Ruano, Isabel
  • Nuciforo, Paolo|||0000-0003-1380-0990
  • Pedrosa, Leire|||0000-0002-1852-4975
  • Marques, Carlota|||0000-0002-8308-5630
  • Braña, Irene|||0000-0002-1068-9601
  • Garralda, Elena|||0000-0002-4412-7842
  • Vieito, María|||0000-0001-7531-343X
  • Squatrito, Juan|||0000-0002-4593-3790
  • Pineda, Estela|||0000-0003-2128-747X
  • Graus Ribas, Francesc|||0000-0002-8924-8322
  • Espejo, Carmen|||0000-0001-9949-5901
  • Sahuquillo Barris, Juan|||0000-0003-0713-5875
  • Tabernero, Josep|||0000-0002-2495-8139
  • Seoane Suárez, Joan|||0000-0002-6541-5974
Cancer response to immunotherapy depends on the infiltration of CD8 T cells and the presence of tumor-associated macrophages within tumors. Still, little is known about the determinants of these factors. We show that LIF assumes a crucial role in the regulation of CD8 T cell tumor infiltration, while promoting the presence of protumoral tumor-associated macrophages. We observe that the blockade of LIF in tumors expressing high levels of LIF decreases CD206, CD163 and CCL2 and induces CXCL9 expression in tumor-associated macrophages. The blockade of LIF releases the epigenetic silencing of CXCL9 triggering CD8 T cell tumor infiltration. The combination of LIF neutralizing antibodies with the inhibition of the PD1 immune checkpoint promotes tumor regression, immunological memory and an increase in overall survival.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition

  • Jiménez, Isabel|||0000-0002-5144-861X
  • Carabia, Júlia
  • Bobillo, Sabela|||0000-0001-7381-680X
  • Palacio-García, Carles|||0000-0002-9085-3327
  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Pagès Geli, Carlota|||0000-0001-9200-3943
  • Nieto Sáchica, Juan Camilo|||0000-0002-3400-1488
  • Castellvi, Josep|||0000-0001-5745-9996
  • Martinez-Ricarte, Fran|||0000-0003-4567-0828
  • Escoda, Lourdes|||0000-0003-3288-9716
  • Perla, Cristóbal
  • Céspedes Torrez, Dennis H.
  • Boix, Joan
  • Purroy i Zuriguel, Noèlia
  • Puigdefàbregas, Lluís
  • Seoane Suárez, Joan|||0000-0002-6541-5974
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
  • Crespo, Marta|||0000-0002-7732-7808
Patients diagnosed with primary central nervous system lymphoma (PCNSL) often face dismal outcomes due to the limited availability of therapeutic options. PCNSL cells frequently have deregulated B-cell receptor (BCR) signaling, but clinical responses to its inhibition using ibrutinib have been brief. In this regard, blocking nuclear export by using selinexor, which covalently binds to XPO1, can also inhibit BCR signaling. Selinexor crosses the blood-brain barrier and was recently shown to have clinical activity in a patient with refractory diffuse large B-cell lymphoma in the CNS. We studied selinexor alone or in combination with ibrutinib in pre-clinical mouse models of PCNSL. Orthotopic xenograft models were established by injecting lymphoma cells into the brain parenchyma of athymic mice. Tumor growth was monitored by bioluminescence. Malignant cells and macrophages were studied by immunohistochemistry and flow cytometry. Selinexor blocked tumor growth and prolonged survival in a bioluminescent mouse model, while its combination with ibrutinib further increased survival. CNS lymphoma in mice was infiltrated by tumor-promoting M2-like macrophages expressing PD-1 and SIRPα. Interestingly, treatment with selinexor and ibrutinib favored an anti-tumoral immune response by shifting polarization toward inflammatory M1-like and diminishing PD-1 and SIRPα expression in the remaining tumor-promoting M2-like macrophages. These data highlight the pathogenic role of the innate immune microenvironment in PCNSL and provide pre-clinical evidence for the development of selinexor and ibrutinib as a new promising therapeutic option with cytotoxic and immunomodulatory potential. The online version of this article (10.1007/s11060-020-03580-y) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas

  • Bobillo, Sabela|||0000-0001-7381-680X
  • Crespo, Marta|||0000-0002-7732-7808
  • Escudero, Laura|||0000-0001-7385-673X
  • Mayor, Regina
  • Raheja, Priyanka
  • Carpio Segura, Cecilia del Carmen|||0000-0001-9346-0134
  • Rubio-Perez, Carlota|||0000-0002-1921-168X
  • Tazon-Vega, Barbara
  • Palacio-García, Carles|||0000-0002-9085-3327
  • Carabia, Júlia
  • Jimenez, Isabel
  • Nieto Sáchica, Juan Camilo|||0000-0002-3400-1488
  • Montoro Gómez, Maria Julia|||0000-0001-9532-7417
  • Martinez-Ricarte, Francisco
  • Castellvi, Josep|||0000-0001-5745-9996
  • Simó Perdigó, Marc|||0000-0002-3982-8759
  • Puigdefabregas, Lluis
  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
  • Seoane Suárez, Joan|||0000-0002-6541-5974
The levels of cell free circulating tumor DNA (ctDNA) in plasma correlate with treatment response and outcome in systemic lymphomas. Notably, in brain tumors, the levels of ctDNA in the cerebrospinal fluid (CSF) are higher than in plasma. Nevertheless, their role in central nervous system (CNS) lymphomas remains elusive. We evaluated the CSF and plasma from 19 patients: 6 restricted CNS lymphomas, 1 systemic and CNS lymphoma, and 12 systemic lymphomas. We performed whole exome sequencing or targeted sequencing to identify somatic mutations of the primary tumor, then variant-specific droplet digital polymerase chain reaction was designed for each mutation. At time of enrollment, we found ctDNA in the CSF of all patients with restricted CNS lymphoma but not in patients with systemic lymphoma without CNS involvement. Conversely, plasma ctDNA was detected in only 2 out of 6 patients with restricted CNS lymphoma with lower variant allele frequencies than CSF ctDNA. Moreover, we detected CSF ctDNA in one patient with CNS lymphoma in complete remission and in one patient with systemic lymphoma, 3 and 8 months before CNS relapse was confirmed, indicating that CSF ctDNA might detect CNS relapse earlier than conventional methods. Finally, in two cases with CNS lymphoma, CSF ctDNA was still detected after treatment even though no tumoral cells were observed by flow cytometry (FC), indicating that CSF ctDNA detected residual disease better than FC. In conclusion, CSF ctDNA can detect CNS lesions better than plasma ctDNA and FC. In addition, CSF ctDNA predicted CNS relapse in CNS and systemic lymphomas.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment

  • Rubio-Perez, Carlota|||0000-0002-1921-168X
  • Planas-Rigol, Ester|||0000-0001-5948-2241
  • Trincado Alonso, Juan Luis, 1987-|||0000-0001-5363-3774
  • Bonfill-Teixidor, Ester|||0000-0002-9260-448X
  • Arias, Alexandra
  • Marchese, Domenica|||0000-0002-3036-4580
  • Moutinho, Catia|||0000-0003-3885-0847
  • Serna, Garazi|||0000-0003-2666-0982
  • Pedrosa, Leire|||0000-0002-1852-4975
  • Iurlaro, Raffaella|||0000-0003-1019-6679
  • Martinez-Ricarte, Fran|||0000-0003-4567-0828
  • Escudero, Laura|||0000-0001-7385-673X
  • Cordero Asanza, Esteban|||0000-0003-0464-3014
  • Cicuendez, Marta|||0000-0002-2603-9072
  • Ruiz, Sara
  • Parra, Genís
  • Nuciforo, Paolo|||0000-0003-1380-0990
  • Gonzalez, Josep
  • Pineda, Estela|||0000-0003-2128-747X
  • Sahuquillo Barris, Juan|||0000-0003-0713-5875
  • Tabernero, Josep|||0000-0002-2495-8139
  • Heyn, Holger|||0000-0002-3276-1889
  • Seoane Suárez, Joan|||0000-0002-6541-5974
Brain metastases are the most common tumor of the brain with a dismal prognosis. A fraction of patients with brain metastasis benefit from treatment with immune checkpoint inhibitors (ICI) and the degree and phenotype of the immune cell infiltration has been used to predict response to ICI. However, the anatomical location of brain lesions limits access to tumor material to characterize the immune phenotype. Here, we characterize immune cells present in brain lesions and matched cerebrospinal fluid (CSF) using single-cell RNA sequencing combined with T cell receptor genotyping. Tumor immune infiltration and specifically CD8 + T cell infiltration can be discerned through the analysis of the CSF. Consistently, identical T cell receptor clonotypes are detected in brain lesions and CSF, confirming cell exchange between these compartments. The analysis of immune cells of the CSF can provide a non-invasive alternative to predict the response to ICI, as well as identify the T cell receptor clonotypes present in brain metastasis. The use of CSF for diagnosis of metastatic brain tumors could be of clinical and patient benefit. Here the authors undertake a single-cell RNA analysis of CSF and brain to determine whether the phenotype in the CSF is reflective of the phenotype in the tumor
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A single-cell tumor immune atlas for precision oncology

  • Nieto, Paula
  • Elosua-Bayes, Marc|||0000-0001-5315-815X
  • Trincado Alonso, Juan Luis, 1987-|||0000-0001-5363-3774
  • Marchese, Domenica|||0000-0002-3036-4580
  • Massoni-Badosa, Ramon
  • Salvany, Maria|||0000-0002-8573-4032
  • Henriques, Ana|||0000-0002-2421-4308
  • Nieto Sáchica, Juan Camilo|||0000-0002-3400-1488
  • Aguilar-Fernández, Sergio|||0000-0002-8869-1066
  • Mereu, Elisabetta|||0000-0001-6101-8472
  • Moutinho, Catia|||0000-0003-3885-0847
  • Ruiz, Sara
  • Lorden, Patricia
  • Chin, Vanessa T.
  • Kaczorowski, Dominik|||0000-0002-9205-1934
  • Chan, Chia Ling
  • Gallagher, Richard
  • Chou, Angela|||0000-0003-3925-7295
  • Planas-Rigol, Ester|||0000-0001-5948-2241
  • Rubio-Perez, Carlota|||0000-0002-1921-168X
  • Gut, Ivo|||0000-0001-7219-632X
  • Piulats, Josep M.|||0000-0002-3606-1724
  • Seoane Suárez, Joan|||0000-0002-6541-5974
  • Powell, Joseph E.|||0000-0002-5070-4124
  • Batlle, Eduard|||0000-0003-2422-0326
  • Heyn, Holger|||0000-0002-3276-1889
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma

  • Escudero Monreal, Laura
  • Llort Sales, Anna
  • Arias Piñeiro, Alexandra
  • Diaz-Navarro, Ander
  • Martínez Ricarte, Francisco Ramón
  • Rubio Pérez, Carlota
  • Mayor Ferreras, Regina Gabriela
  • Caratú, Ginevra
  • Martinez Saez, Elena Antima
  • Vázquez Méndez, Josefa Élida
  • Hladun Alvaro, Raquel
  • Gros Subias, Luís
  • Ramon y Cajal Agüeras, Santiago
  • Poca Pastor, Ma Antonia
  • Sahuquillo Barris, Joan
  • Gallego Melcón, Soledad
  • Seoane Suarez, Joan
Genètica del càncer; Càncer del SNC; Càncer pediàtric, Genética del cáncer; Cáncer del SNC; Cáncer pediátrico, Cancer genetics; CNS cancer; Paediatric cancer, The molecular characterisation of medulloblastoma, the most common paediatric brain tumour, is crucial for the correct management and treatment of this heterogenous disease. However, insufficient tissue sample, the presence of tumour heterogeneity, or disseminated disease can challenge its diagnosis and monitoring. Here, we report that the cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) recapitulates the genomic alterations of the tumour and facilitates subgrouping and risk stratification, providing valuable information about diagnosis and prognosis. CSF ctDNA also characterises the intra-tumour genomic heterogeneity identifying small subclones. ctDNA is abundant in the CSF but barely present in plasma and longitudinal analysis of CSF ctDNA allows the study of minimal residual disease, genomic evolution and the characterisation of tumours at recurrence. Ultimately, CSF ctDNA analysis could facilitate the clinical management of medulloblastoma patients and help the design of tailored therapeutic strategies, increasing treatment efficacy while reducing excessive treatment to prevent long-term secondary effects., We would like to thank the patients at the Vall d’Hebron Hospital that were enrolled in the study and their families. The study was undertaken with the support of the Fundación Asociación Española contra el Cáncer (AECC), FERO (EDM), Ramón Areces Foundation, Cellex Foundation, BBVA (CAIMI), the ISCIII, FIS (PI16/01278) and the Juan de la Cierva fellowship (L.E). X.S.P. is supported by Ministerio de Economía y Competitividad (MINECO) SAF2013-45836-R and CIBERONC; A.D.N. is supported by the Department of Education of the Basque Government (grant number PRE_2017_1_0100). We thank CERCA Programme/Generalitat de Catalunya for institutional support.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment

  • Rubio Pérez, Carlota
  • Planas Rigol, Ester
  • Trincado, Juan L.
  • Bonfill Teixidor, Ester
  • Arias Piñeiro, Alexandra
  • Marchese, Domenica
  • Iurlaro, Raffaella
  • Martínez Ricarte, Francisco Ramón
  • Escudero Monreal, Laura
  • Cordero Asanza, Esteban Xavier
  • Cicuendez López Ocaña, Marta
  • Nuciforo, Paolo Giovanni
  • Sahuquillo Barris, Joan
  • Tabernero, Josep
  • Seoane Suarez, Joan
  • Serna, Garazi
Microambient del càncer; Immunologia tumoral, Microambiente del cáncer; Inmunología tumoral, Cancer microenvironment; Tumour immunology, Brain metastases are the most common tumor of the brain with a dismal prognosis. A fraction of patients with brain metastasis benefit from treatment with immune checkpoint inhibitors (ICI) and the degree and phenotype of the immune cell infiltration has been used to predict response to ICI. However, the anatomical location of brain lesions limits access to tumor material to characterize the immune phenotype. Here, we characterize immune cells present in brain lesions and matched cerebrospinal fluid (CSF) using single-cell RNA sequencing combined with T cell receptor genotyping. Tumor immune infiltration and specifically CD8+ T cell infiltration can be discerned through the analysis of the CSF. Consistently, identical T cell receptor clonotypes are detected in brain lesions and CSF, confirming cell exchange between these compartments. The analysis of immune cells of the CSF can provide a non-invasive alternative to predict the response to ICI, as well as identify the T cell receptor clonotypes present in brain metastasis., The study was undertaken with the support of the Fundación Asociación Española contra el Cáncer (AECC), FERO (EDM), Ramón Areces Foundation, Cellex Foundation, BBVA (CAIMI), the ISCIII, FIS (PI16/01278), the Ministerio de Ciencia, Innovación y Universidades (SAF2017-89109-P; AEI/FEDER, UE), the Juan de la Cierva formación fellowship (C.R.-P. and L.E.), Sara Borrell fellowship (E.P-R.). We acknowledge support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Program/Generalitat de Catalunya. We also acknowledge the support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, and the Co-financing by the Spanish Ministry of Ministry of Science and Innovation with funds from the European Regional Development Fund (ERDF) corresponding to the 2014–2020 Smart Growth Operating Program.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

  • Janin, Maxime
  • Ortiz‑Barahona, Vanessa
  • Castro de Moura, Manuel
  • Martínez‑Cardús, Anna
  • Llinàs‑Arias, Pere
  • Soler, Marta
  • Arias Piñeiro, Alexandra
  • Cuartas Maza, Ma Isabel
  • Seoane Suarez, Joan
Resultado clínico; Epitranscriptómica; Glioma, Clinical outcome; Epitranscriptomics; Glioma, Resultat clínic; Epitranscriptòmica; Glioma, Tumors have aberrant proteomes that often do not match their corresponding transcriptome profiles. One possible cause of this discrepancy is the existence of aberrant RNA modification landscapes in the so-called epitranscriptome. Here, we report that human glioma cells undergo DNA methylation-associated epigenetic silencing of NSUN5, a candidate RNA methyltransferase for 5-methylcytosine. In this setting, NSUN5 exhibits tumor-suppressor characteristics in vivo glioma models. We also found that NSUN5 loss generates an unmethylated status at the C3782 position of 28S rRNA that drives an overall depletion of protein synthesis, and leads to the emergence of an adaptive translational program for survival under conditions of cellular stress. Interestingly, NSUN5 epigenetic inactivation also renders these gliomas sensitive to bioactivatable substrates of the stress-related enzyme NQO1. Most importantly, NSUN5 epigenetic inactivation is a hallmark of glioma patients with long-term survival for this otherwise devastating disease., This work was supported by a European Research Council (ERC) Advanced Grant under the European Community’s Seventh Framework Program (FP7/2007-2013)/ERC Grant Agreement No. 268626—EPINORC project (to M. Esteller), the Ministerio de Economía y Competitividad (MINECO) under Grant No. SAF2014-55000-R (to M. Esteller) and the Instituto de Salud Carlos III (ISCIII), under the FIS PI16/01278 Project (to J. Seoane), the Integrated Project of Excellence no. PIE13/00022 (ONCOPROFILE) (to M. Esteller), CIBER 2016 CB16/12/00312 (CIBERONC) (to M. Esteller), co-financed by the European Development Regional Fund, ‘A way to achieve Europe’ ERDF, the AGAUR—Catalan Government (Project No. 2009SGR1315 and 2014SGR633) (to M. Esteller), the Cellex Foundation (to M. Esteller), Obra Social “La Caixa” (to M. Esteller), the CERCA Program and the Health and Science Departments of the Catalan Government (Generalitat de Catalunya) (to M. Esteller) and a grant from the National Health and Medical Research Council of Australia (APP1061551, to TP). M.W. Boudreau is a member of the NIH Chemistry-Biology Interface Training Program (T32-GM070421).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition

  • Jiménez Bernal, Isabel
  • Carabia Juberó, Júlia
  • Bobillo Varela, Sabela
  • Palacio García, Carlos
  • Abrisqueta, Pau
  • Nieto Sáchica, Juan Camilo
  • Castellví Vives, Josep
  • Martínez Ricarte, Francisco Ramón
  • Boix, Joan
  • Purroy Zuriguel, Noelia
  • Puigdefabregas Horta, Lluis
  • Seoane Suarez, Joan
  • Crespo Maull, Marta
  • Pagès Geli, Carlota
  • Bosch, Francesc
XPO1; BTK; Sistema immunitari innat, XPO1; BTK; Sistema inmune innato, XPO1; BTK; Innate immune system, Background Patients diagnosed with primary central nervous system lymphoma (PCNSL) often face dismal outcomes due to the limited availability of therapeutic options. PCNSL cells frequently have deregulated B-cell receptor (BCR) signaling, but clinical responses to its inhibition using ibrutinib have been brief. In this regard, blocking nuclear export by using selinexor, which covalently binds to XPO1, can also inhibit BCR signaling. Selinexor crosses the blood–brain barrier and was recently shown to have clinical activity in a patient with refractory diffuse large B-cell lymphoma in the CNS. We studied selinexor alone or in combination with ibrutinib in pre-clinical mouse models of PCNSL. Methods Orthotopic xenograft models were established by injecting lymphoma cells into the brain parenchyma of athymic mice. Tumor growth was monitored by bioluminescence. Malignant cells and macrophages were studied by immunohistochemistry and flow cytometry. Results Selinexor blocked tumor growth and prolonged survival in a bioluminescent mouse model, while its combination with ibrutinib further increased survival. CNS lymphoma in mice was infiltrated by tumor-promoting M2-like macrophages expressing PD-1 and SIRPα. Interestingly, treatment with selinexor and ibrutinib favored an anti-tumoral immune response by shifting polarization toward inflammatory M1-like and diminishing PD-1 and SIRPα expression in the remaining tumor-promoting M2-like macrophages. Conclusions These data highlight the pathogenic role of the innate immune microenvironment in PCNSL and provide pre-clinical evidence for the development of selinexor and ibrutinib as a new promising therapeutic option with cytotoxic and immunomodulatory potential., This work was supported by research funding from the Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias (PI17/00950, M.C., PI17/00943, F.B, PI18/01392, P.A., PI16/01278, J.S) cofinanced by the European Regional Development Fund (ERDF); Fundación Asociación Española Contra el Cáncer (M.C. and P.A.) and Gilead Fellowships (GLD16/00144, GLD18/00047, F.B). M.C. holds a contract from Ministerio de Ciencia, Innovación y Universidades (RYC-2012-12018). S.B. is the recipient of a postdoctoral fellowship from Fundación Alfonso Martin Escudero.